The many faces of follicular variant of papillary thyroid carcinoma

Pathology Case Reviews

Volumn 14, Issue 6, 2009, Pages 214-218

  Livolsi, Virginia A ^a   Baloch, Zubair W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN PATCHED; PROTEIN RET; RADIOACTIVE IODINE; RAS PROTEIN; TRANSCRIPTION FACTOR PAX8;

CANCER CLASSIFICATION; CANCER INVASION; CANCER MORPHOLOGY; CANCER PATIENT; CELL NUCLEUS; CLINICAL FEATURE; CYTODIAGNOSIS; ENCAPSULATION; FOLLOW UP; GENE MUTATION; GENE TRANSLOCATION; HUMAN; LOBECTOMY; LYMPH NODE METASTASIS; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; THYROID FOLLICLE; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

EID: 74249116174     PISSN: 10829784     EISSN: 15334015     Source Type: Journal    
DOI: 10.1097/PCR.0b013e3181c75e9b     Document Type: Review

References (46)

1. Lindsay S. Carcinoma of the Thyroid Gland: A Clinical and Pathologic Study of 239 Patients at the University of California Hospital. Springfield, IL: Charles C. Thomas; 1960.
2. Chen KT, Rosai J. Follicular variant of thyroid papillary carcinoma: a clinicopathologic study of six cases. Am J Surg Pathol. 1977;1:123-130.
3. Meissner WA. Follicular carcinoma of the thyroid; frozen section diagnosis. Am J Surg Pathol. 1977;1:171-175.
4. DeLellis RA, Lloyd RD, Heitz PU, et al, eds. WHO: Pathology and Genetics. Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
5. Rosai J, Carcangui ML, DeLellis RA. Tumors of the Thyroid Gland. 3rd series (fascicle 5). Washington, DC: Armed Forces Institute of Pathology; 1992.
6. LiVolsi VA. Surgical Pathology of The Thyroid. Philadelphia, PA: WB Saunders; 1990.
7. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid. 1994;4:233-236.
8. Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336-1340.
9. Hirokawa M, Carney JA, Goellner JR, et al. Observer variation of encapsulated follicular lesions of the thyroid gland. Am J Surg Pathol. 2002;26:1508-1514.
10. Renshaw AA, Gould EW. Why there is tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117:19-21.
11. Chan JK. Strict criteria should be applied in the diagnosis of encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002; 117:16-18.
12. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117:143-150.
13. Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008; 130:736-744.
14. Logani S, Gupta PK, LiVolsi VA, et al. Thyroid nodules with FNA cytology suspicious for follicular variant of papillary thyroid carcinoma: follow-up and management. Diagn Cytopathol. 2000;23:380-385.
15. Zacks JF, de las Morenas A, Beazley RM, et al. Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid. Diagn Cytopathol. 1998;18:87-90.
16. Baloch ZW, Livolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008;36:425-437.
17. Verhulst P, Devos P, Aubert S, et al. A score based on microscopic criteria proposed for analysis of papillary carcinoma of the thyroid. Virchows Arch. 2008;452:233-240.
18. Baloch ZW, LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. J Clin Pathol. 2007;60:244-250.
19. Williams ED, Abrosimov A, Bogdanova TI, et al. Two proposals regarding the terminology of thyroid tumors [Guest Editorial]. Int J Surg Pathol. 2000;8:181-183.
20. Baloch ZW, LiVolsi VA. Pathologic diagnosis of papillary thyroid carcinoma: today and tomorrow. Expert Rev Mol Diagn. 2005;5:573-584.
21. Kaur A, Jayaram G. Thyroid tumors: cytomorphology of follicular neoplasms. Diagn Cytopathol. 1991;7:469-472.
22. Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26:41-44.
23. LiVolsi VA, Baloch ZW. Follicular neoplasms of the thyroid: view, biases, and experiences. Adv Anat Pathol. 2004;11:279-287.
24. Saggiorato E, De Pompa R, Volante M, et al. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer. 2005;12:305-317.
25. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009;117:195-202.
26. Fusco A, Chiappetta G, Hui P, et al. Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. Am J Pathol. 2002;160:2157-2167.
27. Nakamura N, Erickson LA, Jin L, et al. Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma. Endocr Pathol. 2006;17:213-223.
28. Barroeta JE, Baloch ZW, Lal P, et al. Diagnostic value of differential expression of CK19, Galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis. Endocr Pathol. 2006;17:225-234.
29. Prasad ML, Pellegata NS, Huang Y, et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. Mod Pathol. 2005;18:48-57.
30. Sobrinho-Simoes M, Preto A, Rocha AS, et al. Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch. 2005;447:787-793.
31. Meissner W, Warren S. Tumors of the Thyroid Gland. Washington, DC: Armed Forces Institute of Pathology; 1969.
32. Rivera M, Tuttle RM, Patel S, et al. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009;19:119-127.
33. Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000;13:861-865.
34. Mizukami Y, Nonomura A, Hayashi Y, et al. Late bone metastasis from an encapsulated follicular carcinoma of the thyroid without capsular and vascular invasion. Pathol Int. 1996;46:457-461.
35. Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2000;13:123-130.
36. Hunt JL, Dacic S, Barnes EL, et al. Encapsulated follicular variant of papillary thyroid carcinoma. Am J Clin Pathol. 2002;118:602-603, author reply 605-606.
37. Giordano TJ, Kuick R, Thomas DG, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutationspecific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646-6656.
38. Wreesmann VB, Ghossein RA, Hezel M, et al. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity. Genes Chromosomes Cancer. 2004;40:355-364.
39. Wreesmann VB, Sieczka EM, Socci ND, et al. Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker. Cancer Res. 2004;64:3780-3789.
40. Thomas GA, Bunnell H, Cook HA, et al. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solidfollicular variant. J Clin Endocrinol Metab. 1999;84:4232-4238.
41. Nikiforov YE, Nikiforova MN, Gnepp DR, et al. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Oncogene. 1996;13:687-693.
42. Zhu Z, Gandhi M, Nikiforova MN, et al. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations. Am J Clin Pathol. 2003;120:71-77.
43. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008;5:6.
44. Sapio MR, Posca D, Raggioli A, et al. Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings. Clin Endocrinol (Oxf). 2007;66:678-683.
45. Pizzolanti G, Russo L, Richiusa P, et al. Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement. Thyroid. 2007;17:1109-1115.
46. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94:2092-2098.